Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
Clinical trial NCT00878709 · COMPLETED
Trial details
- NCT number
- NCT00878709
- Sponsor
- Puma Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-09
- Primary completion
- 2014-08-21
- Enrollment
- 2840
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.